title: Endovascular treatment in diseases of the descending thoracic aorta: 6-year results of a single center.
abstract: OBJECTIVE
  The purpose of this study was to evaluate endovascular treatment in diseases of the descending thoracic aorta.
  
  
  METHODS
  This study was designed as a single center's (university hospital) experience. Over a 6-year period (1995 to 2001), thoracic endografts were placed in 74 patients with a diseased descending thoracic aorta who were at high risk for conventional open surgical repair: 34 had atherosclerotic aneurysms, six had posttraumatic aneurysms, 14 had type B dissection with aneurysmal dilatation of the false lumen, 12 had isthmic transections from blunt trauma, five had thoracoabdominal aneurysms (treated with a combined procedure), two had aortic coarctation, and one had an aortobronchial fistula. Twenty-six procedures (35.1%) were conducted as emergencies, and 48 (64.9%) were elective. The feasibility of endovascular treatment and sizing of stent grafts were determined with preoperative spiral computed tomography and intraoperative angiography.
  
  
  RESULTS
  Endovascular operations were completed successfully in all 74 patients; postprocedural conversion to open repair was necessary in three cases. The overall 30-day mortality rate was 9.5% (seven deaths). Temporary neurologic deficits developed in two patients; not one patient had permanent paraplegia. The primary endoleak rate was 20.3% (15 patients). The mean follow-up period was 22 months (range, 3 to 72 months). Five deaths occurred in the follow-up period, and three patients needed secondary conversion to open repair 2, 3, and 14 months after initial endografting.
  
  
  CONCLUSIONS
  Endoluminal treatment in diseases of the thoracic descending aorta is feasible and may offer results as good as the open method.
authors.affiliation: Department of Thoracic and Vascular Surgery, University of Ulm, Ulm, Germany. karl-heinz.orend@medizin.uni-ulm.de
authors.forename: K H
authors.initials: KH
authors.lastname: Orend
authors.forename: R
authors.initials: R
authors.lastname: Scharrer-Pamler
authors.forename: X
authors.initials: X
authors.lastname: Kapfer
authors.forename: T
authors.initials: T
authors.lastname: Kotsis
authors.forename: J
authors.initials: J
authors.lastname: Görich
authors.forename: L
authors.initials: L
authors.lastname: Sunder-Plassmann
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000784:Aortic Dissection / Q000628:therapy; D001013:Aorta, Thoracic / Q000293:injuries; D017544:Aortic Aneurysm, Abdominal / Q000628:therapy; D017545:Aortic Aneurysm, Thoracic / Q000628:therapy; D001017:Aortic Coarctation / Q000628:therapy; D001018:Aortic Diseases / Q000401:mortality / Q000628:therapy*; D001161:Arteriosclerosis / Q000628:therapy; D001983:Bronchial Fistula / Q000628:therapy; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015607:Stents; D016896:Treatment Outcome; D016157:Vascular Fistula / Q000628:therapy